Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease

Clinical and Experimental Immunology

Volumn 108, Issue 1, 1997, Pages 42-46

  Giacomelli, R ^a   Cipriani, P ^a   Lattanzio, R ^a   Di Franco, M ^b   Locanto, M ^a   Parzanese, I ^a   Passacantando, A ^a   Ciocci, A ^b   Tonietti, G ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CD30; Systemic sclerosis; T cell

Indexed keywords

CD30 ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HELPER CELL; HUMAN; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; T LYMPHOCYTE SUBPOPULATION;

EID: 0030981805     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-991.x     Document Type: Article

References (34)

1. Roumm AD, Whiteside TL, Medseger TA Jr, Rodnan GP. Lymphocytes in the skin of patients with progressive systemic sclerosis. Arthritis Rheum 1984; 27:645-53.
2. Paul WE, Seder RA. Lymphocyte responses and cytokines review. Cell 1994; 76:241-51.
3. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12:227-57.
4. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-46.
5. Druet P, Sheela R, Pelletier L. Th1 and Th2 cells in autoimmunity. J Exp Immunol 1995; 101 (Suppl. 1): 9-12.
6. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner H, Hafler DA. Increased frequency of interleukin-2 responsible T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994; 179:973-84.
7. De Carli M, D'Elios M, Mariotti S, Marcocci C, Pinchera A, Chretien I, Romagnani S, Del Pete GF. Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J Clin Endoc Metab 1993; 77:1120-4.
8. Llorente L, Zou W, Levy Y et al. Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995; 181:839-44.
9. Falini B, Pileri S, Pizzolo G et al. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995; 85:1-14.
10. + T cells producing Th2 cytokines. FASEB 1995; 9:81-86.
11. + clones in human immunodeficiency virus infection. J Exp Med 1994; 180:2407-11.
12. Andreesen R, Osterholz J, Lohr GW, Bross KJ. A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts. Blood 1984; 63:1299-302.
13. Romagnani S, Del Prete G, Maggi E, Chilosi M, Caligaris-Cappio F, Pizzolo G. CD30 and type 2 T helper (Th2) responses. J Leukoc Biol 1995; 57:726-30.
14. Josimovic-Alasevic O, Durkop H, Schwarting R, Backe E, Stein H, Diamantstein T. Ki-1 (CD30) antigen is released by Ki-1 positive tumor-cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell colture supernatants and in serum by enzyme-linked immunosorbent assay. Eur J Immunol 1989; 19:157-62.
15. + T cell involvement in the inflamed joints. Clin Exp Immunol 1995; 102:547-50.
16. Caligaris-Cappio F, Bertero MT, Converso M et al. Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity. Clin Exp Rheumatol 1995; 13:339-43.
17. Famularo A, Giacomelli R, Alesse E et al. Polyclonal B lymphocyte activation in progressive systemic sclerosis. J Clin Lab Immunol 1989; 29:59-63.
18. Postlethwaite A. Early immune events in scleroderma. Rheum Dis Clin Noth Am 1990; 16:125-40.
19. Needleman BW, Wigley FM, Stair RW et al. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor α, and interferon γ levels in sera from patients with scleroderma. Arthritis Rheum 1992; 35:67-72.
20. Giacomelli R, Cipriani P, Danese C et al. Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not tranforming growth factor β1. J Rheumatol 1996; 23:291-6.
21. Famularo G, Procopio A, Giacomelli R et al. Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis. Clin Exp Immunol 1990; 81:368-72.
22. Masi AT, Rodnan GP, Medsger TA et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-90.
23. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15:202-5.
24. Brennan P, Silman A, Black C et al. Reliability of skin involvement measures in scleroderma. Br J Rheumatol 1992; 31:456-60.
25. Anderson GP, Coyle AJ. Th2 and 'Th2-like' cells in allergy and asthma: pharmacological perspectives. TiPS 1994; 15:324-32.
26. Romagnani S, Maggi E. Th1 vs. Th2 responses in AIDS. Curr Opin Immunol 1994; 4:616-22.
27. Charlton B, Lafferty KJ. The Th1/Th2 balance in autoimmunity. Curr Opin Immunol 1995; 7:793-8.
28. Rus V, Svetic A, Nguyen P, Gause WC, Via CS. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-vs.-host disease. J Immunol 1995; 155:2396-406.
29. Kantor TV, Friberg D, Medsger TA Jr, Buckingham RB, Whiteside TL. Cytokine production and serum levels in systemic sclerosis. Clin Immunol Immunopathol 1992; 65:278-85.
30. Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991; 12:17-23.
31. Thornhill MH, Kyan-Aung U, Haskard DO. IL4 increases human endothelial cell adhesiveness for T cells but not for neutrofils. J Immunol 1990; 144:3060-5.
32. Rosenbloom J, Feldman G, Freundlich B, Jimenez S. Inhibition of excessive scleroderma fibroblast collagen production by recombinant gamma-interferon. Arthritis Rheum 1986; 29:851-6.
33. Renkonen R, Ristimaki A, Itayry P. Interferon gamma protects human endothelial cells from lymphokine-activated killer cell mediated lysis. Eur J Immunol 1988; 18:1839-42.
34. Black CM. Measurement of skin invovement in scleroderma. J Rheumatol 1995; 22:1217-8.